Instituto Portugues de Oncologia do Porto

Porto 4200-072

1 studies enrolling now · 4 studies all time

What they study most

Acral Melanoma, Advanced Cholangiocarcinoma, Advanced Solid Tumor, Basal Cell Carcinoma, Bladder Cancer, Cancer With A High Tumor Mutational Burden, Cervical Cancer, Cervical Cancers, Clear Cell Renal Cell Carcinoma, Colorectal Cancer (MSI-H), Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma

Studies at this site

• A Beta-only IL-2 ImmunoTherapY Study — Recruiting now
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study of TAS-120 in Patients With Metastatic Breast Cancer — Stopped early
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early